New device sucks out deadly heart infections without open surgery
NCT ID NCT07282002
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device called AngioVac that uses suction to remove infected growths (vegetations) from the right side of the heart in people with infective endocarditis. The trial will enroll 30 adults with large vegetations and track survival, infection clearance, and complications within 30 days. If it works, it could offer a less invasive alternative to surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AngioVac System (a vacuum device to suction out infected growths from the heart)
What this could lead to
If successful, this could offer a less invasive way to remove dangerous heart infections, potentially reducing the need for open-heart surgery.
What could go wrong
This is a small, early feasibility study with only 30 participants, so results may not apply broadly. Risks include bleeding, heart perforation, or device-related complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIVE ENDOCARDITIS (IE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••